Pyxis Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-57.8	-73.79	-120.72	-75.98	-12.83	-2.77
Depreciation & Amortization	3.53	2.59	1.84	1.25	0.83	0
Share-Based Compensation	16.38	16.95	15.76	6.44	0.04	0.03
Other Operating Activities	-26.69	-16.45	13.78	32.96	1.87	0.51
Operating Cash Flow	-64.58	-70.71	-89.34	-35.33	-10.08	-2.24
Capital Expenditures	-2.56	-6.73	-6.4	-0.54	-1.48	0
Acquisitions	6.66	6.66	0	-0.05	0	0
Change in Investments	-28.06	-104.78	0	0	0	0
Investing Cash Flow	-23.95	-104.85	-6.4	-0.59	-1.48	0
Share Issuance / Repurchase	64.08	6.37	0.18	152.46	0.04	0.01
Other Financing Activities	-0.64	-0.45	-	151.58	-	21.94
Financing Cash Flow	63.44	5.93	0.18	304.04	0.04	21.96
Net Cash Flow	-25.09	-169.63	-95.55	268.13	-11.53	19.72
Free Cash Flow	-67.14	-77.44	-95.73	-35.87	-11.57	-2.24
Free Cash Flow Margin	-415.80%	-	-	-	-	-
Free Cash Flow Per Share	-1.31	-1.94	-2.90	-4.22	-11.22	-0.52

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).